Answer
Pamidronate disodium treats tumour-induced hypercalcaemia and Paget’s disease of bone and, alongside tumour-specific treatment, prevents skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, hypercalcaemia and bone pain) in patients with breast cancer with bone metastases or multiple myeloma with bone lesions.
Sources for this answer
- Pamidronate Disodium 9 mg/ml Sterile ConcentrateHospira UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 10Document updated
Sources checked